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Introduction
Nicotine is one of the major psychoactive constituents of tobacco smoke that has a strong abuse potential in humans and laboratory animals. The most common withdrawal symptoms in humans include nicotine craving, irritability, anxiety, difficulty of concentration, increased appetite and 
Material and Methods

Animals
Male Wistar rats (Charles River, Germany) weighing 220-250 g (9 weeks old) at the beginning of the experiment were used. The animals were housed 4-7 per cage (58 cm x 37 cm x 20 cm) in a colony room maintained at 21 ± 1ºC and 40-50% humidity under a 12-h light-dark cycle (lights on at 6:00). Rodent chow and water were available ad libitum. All the experiments were conducted during the light phase of the light-dark cycle (8:00-14:00), in accordance with The National Institutes of Health Guide for the Care and Use of Laboratory Animals and the approval of the Bioethics Commission (at the Institute of Pharmacology Polish Academy of Sciences) and compliant with the Polish Law (August 21, 1997). All the efforts were made to minimize animal suffering and to reduce the number of rats used.
Repeated nicotine administration
Drugs
(-)-Nicotine bitartrate (Sigma-Aldrich, USA) was dissolved in 0.9% saline. The pH was adjusted to 7.0 using 20% NaOH. Drug was injected subcutaneously in a volume of 1 ml/kg. The dose of nicotine (expressed as that of the free base) and pretreatment time were optimized in our laboratory, as described previously (Zaniewska et al., 2010) .
Measurement of depression-like behavior in animals withdrawn from nicotine
Rats were given nicotine (0.4 mg/kg) or vehicle (1 ml/kg) for 5 days in home cages. The forced swim test was performed on day 3 of nicotine withdrawal.
Forced swim test
On the first day of forced swim test, rats withdrawn from nicotine were placed individually in a cylinder (50-cm high and 23 cm in diameter) filled with 30 cm of water (25 ± 1°C) for 15 min (the pre-test). They were then removed, dried with towels, and placed in a warmer enclosure for 15 min before they were returned to their home cages. The cylinders were emptied and cleaned between rats. 24 h after the pre-test, the rats were retested for 5 min under identical conditions. Two blinded observers scored each retest session. The following parameters were measured manually: the immobility, swimming and climbing. A rat was rated to be immobile if it was making only movements necessary to keep its head above water; swimming was recorded if a rat was actively making swimming movement that caused it to move within the center of cylinder and swim below the surface of water (diving); climbing behavior was recorded if a rat was making forceful thrashing movements with its forelimbs against the walls of cylinder.
Withdrawal from chronic nicotine treatment
Animals were given nicotine (0.4 mg/kg) or vehicle (1 ml/kg) for 5 days in home cages. 
Quantitative receptor autoradiography
Immediately after decapitation, the brains were dissected, frozen on dry-ice and stored at -70°C until use. Frozen brains were cut on a cryostat (Leica Cm 1850, Germany) at -22 ± 1°C. Images were read by Image Reader v.1.1 (The Bass-5000 IP, Fujifilm). Quantitative analysis of autoradiograms was performed using Multi Gauge 3.0 software (Fujifilm). Optical densities of grey values on the film (relative optical density) were converted into bound radioactivity using the standard polynomial regression curve as a standard. Optical densities, which were the differences between the optical density of T and NS binding, were expressed as nCi/mg tissue relative to the specific activity of the appropriate radioligand. Changes in receptor labeling are expressed in fmol of bound radioligand per mg of tissue (± SEM) and are also presented as the mean percentage of changes with relation to the control value (100%). The following editing parameters were calculated: the level of site-specific editing of the 5-HT 2C receptor mRNA (%), the frequency of observed 5-HT 2C receptor mRNA variants (%) and the frequency of predicted 5-HT 2C receptor protein isoform (%).
Statistical Analysis
Data are expressed as means (± SEM). Comparisons between means representing changes from control values were made using Student's t-test. All comparisons were made with an experiment wise type I error rate (α) set at p < 0.05.
Results
Nicotine withdrawal increases immobility time and reduces swimming behavior in rats withdrawn from nicotine
On day 3 of withdrawal from repeated (for 5 days) nicotine treatment a statistically significant increase in immobility time (p < 0.001) and decrease in swimming behavior (p < 0.05) was observed ( Fig. 3 ).
Nicotine withdrawal alters 5-HT 2A and 5-HT 2C receptor binding in various brain structures
We first analyzed the effect of nicotine withdrawal on radioligand binding to 5-HT 2A and 5-HT 2C receptors in brains of rats repeatedly (for 5 days) treated with vehicle or nicotine. On day 3 of nicotine withdrawal, a lower (33%) level of 5-HT 2C receptor labelling was observed in the ventral dentate gyrus, but higher (by 17%) levels of binding were seen in the choroid plexus (Tab. 2).
Nicotine withdrawal changes the expression levels of 5-HT 2A receptors, but not 5-HT 2C receptors
We next evaluated whether the nicotine withdrawal changes the expression levels of 5-HT 2A and 5-HT 2C receptors in the hippocampus and ventral tegmental area.
The expression level of 5-HT 2A receptor gene measured by real time PCR on day 3 of withdrawal from repeated nicotine administration significantly decreased in the whole hippocampus (62%) and ventral tegmental area (57%) (Fig. 4A, B ).
No change in the level of mRNA encoding for 5-HT 2C receptors was observed in the whole hippocampus or ventral tegmental area in rats withdrawn from chronic nicotine administration (Fig. 5A, B) .
Nicotine withdrawal affects 5-HT 2C receptor mRNA editing
We assessed whether the editing of 5-HT 2C receptor mRNA in the hippocampus and ventral tegmental area is altered by nicotine withdrawal.
Deep sequencing analysis of 5-HT 2C receptor mRNA editing in rats treated repeatedly with vehicle revealed that in the whole hippocampus and ventral tegmental area the highest frequency (12-21%) was detected for ABD, AB, ABE and ABCD receptor mRNA variants (Tabs. 3, 4). Out of the 24 predicted protein isoforms, the most abundant in either of the above brain structures were VNV, VNI, VDI and VSV 5-HT 2C receptor isoforms (Tabs. 3, 4). Editing was significantly lower at the A (8%; p = 0.028) and B (9%; p = 0.036) site in the hippocampus compared with the ventral tegmental area (Fig. 6A, B ).
Repeated treatment with nicotine followed by a three-day withdrawal period produced a statistically significant decrease (30%; p = 0.043) in the editing level at the E site in the hippocampus; a trend toward reduction (5%; p = 0.063) was also noted at the C editing site (Fig.   6A ). At the same time, the frequency of EC, CD and ECD 5-HT 2C receptor mRNA variants (corresponding to IGI, ISV and IGV protein isoform, respectively) was decreased (by 19, 32 and 42%, respectively) in nicotine withdrawn animals as compared to control group, but this did not reach statistical significance (p = 0.14, 0.38 and 0.25, respectively) (Tab. 3).
In the ventral tegmental area of nicotine withdrawn animals, the frequency of CD mRNA variant, which corresponds to ISV receptor protein isoform, significantly decreased (28%; p = 0.0082) (Tab. 4). The site-specific editing of 5-HT 2C receptor mRNA in the ventral tegmental area was not altered by the drug treatment (Fig. 6B ). On the basis of our 5-HT 2A receptor autoradiography studies using receptor antagonist In the present work, we also report dramatic decreases in To identify mechanisms responsible for the alteration in radioligand binding in the hippocampus we first performed real time PCR analysis, but no significant changes in the transcript level of 5-HT 2C receptors were seen, suggesting the existence of another mechanism explaining the changes in receptor binding. Using a deep sequencing method, we discovered decrease in the editing at the E site and a tendency for a reduction at the C site in the hippocampus. We also found pronounced, but non-significant, reduction in the expression of the ECD 5-HT 2C receptor mRNA variant. It might be speculated that the expression of the predicted IGV receptor isoform (encoded by ECD) was also reduced, however, caution must be taken when estimating the receptor isoform expression directly from mRNA levels (e.g., 5-HT 2A receptors, see above).
Discussion
To our knowledge, this study provides the first evaluation of 5-HT 2C receptor RNA editing patterns in rats with a putative depression-like phenotype following nicotine withdrawal.
In agreement with our findings, clinical data show the reduction in editing efficiency across all editing sites and frequency of all transcripts edited at E and C in the prefrontal cortex of Therefore, in opposite direction, we could expect that decrease in editing at E and C sites (i.e., decrease in the expression of Gly-containing receptor isoforms) during nicotine withdrawal leads to the reduction in radioligand binding to these -more active -receptors. At the behavioral level, this could be reflected by enhanced functional response of these receptors to their agonist (Zaniewska et al., 2010) .
There is some concern, however, regarding the physiological role of changes in editing at sites E and C corresponding to receptor transcripts representing < 2% of all receptor variants.
Since these rare isoforms may be expressed on specific types of neurons or can be linked with specific environmental stimuli, their importance cannot be discounted. Further studies are necessary to target these discrete populations of receptors.
It must be mentioned that there is inconsistency in the brain regions used for autoradiographic and transcript analyses (ventral dentate gyrus vs. whole hippocampus).
Certainly, the use of the same subfields of the hippocampus would provide more consistency between two analyses. However, since the expression of 5-HT 2C receptors in the dorsal hippocampus is sparse (cf. Holmes et al., 1995), it seems doubtful that subtle changes noted in editing of 5-HT 2C receptor RNA are due to the fact that for this analysis we used the whole hippocampus instead of the ventral dentate gyrus.
In the present work we also assessed the 5-HT 2C receptor editing in the ventral tegmental area, a brain area in which we did not observe significant changes in The present treatment approach suffers from certain limitations. In fact, nicotine was experimenter-delivered, in contrast to the voluntary drug intake models that better mirror the addictive behavior in humans. In addition, the duration of exposure of rats to nicotine was very short. Whether the changes in 5-HT 2A receptor density and editing pattern of 5-HT 2C receptor reported in the present study could be "bio-markers" of a depression-like state during nicotine withdrawal is a challenge for future research using more complex behavioral models (e.g., nicotine self-administration) and performing extend analysis on different time-points of nicotine withdrawal.
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